NYSE:AVNS - Avanos Medical Stock Price, Forecast & News

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical Inc (NYSE:AVNS) announced its earnings results on Tuesday, November, 5th. The company reported $0.30 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.32 by $0.02. The business had revenue of $171.40 million for the quarter, compared to analysts' expectations of $179.98 million. Avanos Medical had a negative net margin of 6.20% and a positive return on equity of 3.92%. The company's quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter last year, the business earned $0.37 EPS. View Avanos Medical's Earnings History.

Avanos Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Avanos Medical.

Avanos Medical will be holding an earnings conference call on Tuesday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

6 Wall Street analysts have issued 12 month target prices for Avanos Medical's stock. Their forecasts range from $30.00 to $65.00. On average, they anticipate Avanos Medical's share price to reach $42.00 in the next twelve months. This suggests a possible upside of 41.7% from the stock's current price. View Analyst Price Targets for Avanos Medical.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.

News coverage about AVNS stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Avanos Medical earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Avanos Medical.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Bionik Laboratories (BNKL), NanoVibronix (NAOV) and Allied Healthcare Products (AHPI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Honeywell International (HON), Procter & Gamble (PG), AT&T (T), Verizon Communications (VZ), Cisco Systems (CSCO) and Thermo Fisher Scientific (TMO).

Avanos Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Champlain Investment Partners LLC (6.96%), Paradice Investment Management LLC (4.64%), State Street Corp (3.78%), Victory Capital Management Inc. (3.45%), Victory Capital Management Inc. (3.42%) and Goldman Sachs Group Inc. (3.11%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., FMR LLC, Heartland Advisors Inc., Paradice Investment Management LLC, Jacobs Levy Equity Management Inc., California Public Employees Retirement System and Bank of New York Mellon Corp. View Insider Buying and Selling for Avanos Medical.

AVNS stock was acquired by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Schonfeld Strategic Advisors LLC, Cove Street Capital LLC, Confluence Investment Management LLC, Eagle Asset Management Inc., Madison Asset Management LLC, Barclays PLC and State Street Corp. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $29.65.

Avanos Medical has a market capitalization of $1.42 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.

The official website for Avanos Medical is http://www.halyardhealth.com/.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]